Skip to Main Content
  • Search
    Close
  • Limited Partners
Essex Woodlands Health Ventures
  • About Us
  • Investment Strategy
  • Team
  • Portfolio
  • News
  • Contact Us

ABIOMED, Inc.

Logo

Produces the Impella product line, the world's smallest, minimally invasive, high performance micro blood pump with integrated motors and sensors

Danvers, MA

NASDAQ: ABMD

Contact: Marty Sutter

www.abiomed.com

Formerly Known As: Impella CardioSystems

Related News

Video: ABIOMED CEO on Blowout Earnings

ABIOMED Unveils Cost-Effective Next-Generation Heart Device

ABIOMED Reports Record Revenue of $29.5 Million and Profitability for Second Quarter of Fiscal 2012, Driven by 40% Impella Growth

Who Are the Most Innovative CEOs in Medtech?

ABIOMED Announces Final Protect II Study Results for High-Risk PCI Patient Population at American College of Cardiology 2011 Scientific Session

ABIOMED Announces First FDA-Approved ABIOCORĀ® Implant

ABIOMED Receives 510(k) Clearance from FDA for Impella 2.5 Device

Essex Woodlands   A growth equity and venture capital healthcare investor

  • Palo Alto
  • Houston
  • New York
  • London

All content © 2010 | Legal Disclaimer

Website by Eric Miller Design